Most biotechnology companies have high R&D expenses. There is nothing trivial about that unless this is the first biotech stock you've invested in and are not accustomed to the industry.
No matter how you look at it, 8 years is not the definition of instant gratification. The company makes press releases available that state "an independent analyst has projected Nanologix to produce $900,000 in revenue for 2014". I didn't put that information out, Nanologix did. So when you see something like that and take note of how enthusiastic the investors are over news like that, and then you look at the actual financial statement that says $18,550 in revenue, and this kind of situation happens over and over again, you start to realize that something isn't right here.
News 
Market Data 
Discover 
